Patent application number | Description | Published |
20100285491 | USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE - The invention relates to a method for assessing heart failure in vitro comprising the steps of measuring in a sample the concentration of the marker IGFBP-7, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for IGFBP-7 and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of IGFBP-7 as a marker protein in the assessment of heart failure, a marker combination comprising IGFBP-7 and a kit for measuring IGFBP-7. | 11-11-2010 |
20100285492 | USE OF SLIM-1 IN THE ASSESSMENT OF HEART FAILURE - The invention relates to a method for assessing heart failure in vitro comprising the steps of measuring in a sample the concentration of the marker SLIM-1, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for SLIM-1 and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of SLIM-1 as a marker protein in the assessment of heart failure, a marker combination comprising SLIM-1 and a kit for measuring SLIM-1. | 11-11-2010 |
20110027819 | USE OF SFRP-3 IN THE ASSESSMENT OF HEART FAILURE - Disclosed is a method for assessing heart failure in vitro including the steps of measuring in a sample the concentration of the marker SFRP-3, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for SFRP-3 and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of SFRP-3 as a marker protein in the assessment of heart failure, a marker combination comprising SFRP-3 and a kit for measuring SFRP-3. | 02-03-2011 |
20110165591 | USE OF BIGLYCAN IN THE ASSESSMENT OF HEART FAILURE - The invention relates to a method for assessing heart failure in vitro and involves the steps of measuring in a sample the concentration of the marker biglycan, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for biglycan and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of biglycan as a marker protein in the assessment of heart failure, a marker combination comprising biglycan and a kit for measuring biglycan. | 07-07-2011 |
20120156703 | USE OF MIMECAN IN THE ASSESSMENT OF HEART FAILURE - The disclosure relates to assessing heart failure in vitro by measuring the concentration of the marker mimecan in a sample, and optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration of mimecan and the one or more other marker(s) to reference concentrations of this (or these) marker(s) as established in a reference population. The one or more markers may be selected from the group comprising a natriuretic peptide marker, a cardiac troponin marker, and a marker of inflammation. Also disclosed are the use of mimecan as a marker protein in the assessment of heart failure, a marker combination comprising mimecan, and a kit for measuring mimecan. | 06-21-2012 |
20140193845 | USE OF SFRP-3 IN THE ASSESSMENT OF HEART FAILURE - Disclosed is a method for assessing heart failure in vitro including the steps of measuring in a sample the concentration of the marker SFRP-3, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for SFRP-3 and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of SFRP-3 as a marker protein in the assessment of heart failure, a marker combination comprising SFRP-3 and a kit for measuring SFRP-3. | 07-10-2014 |
Patent application number | Description | Published |
20100041965 | Handheld Sleep Assistant Device and Method - In accordance with one aspect of the present invention, an electrical sleep assistant device, which comprises a handheld case, a display panel, a plurality of biosensors, and a calculation module, is provided. The case has a surface. The display panel is disposed on the surface of the case. The plurality of biosensors are disposed on the surface of the case for collecting a plurality of physiological information. The calculation module is disposed in the case, and coupled to the display panel and the plurality of biosensors. Preferably, a plurality of buttons disposed on the surface of the case, and coupled to the calculation module. | 02-18-2010 |
20100041966 | SLEEP ASSISTANT SYSTEM AND METHOD THEREOF - A sleep assistant method for a sleeper in an environment is provided. The method includes the steps of monitoring a bio-condition of the sleeper to collect a bioinformation of the sleeper; performing a sleep coach mode, which analyzes the bioinformation and provides a sleep knowledge to the sleeper based on the analyzed results; and performing a sleep environment adjusting mode, which adjusts the environment based on the bioinformation. | 02-18-2010 |
20100138096 | Patrol Device And Patrol Path Planning Method For The Same - The present invention relates to a patrol device and a patrol path planning method. The patrol device includes an operating unit configured to establish a plurality of patrol paths, each of which has an Average Patrol Omission (APO) value and an Average Patrol Quality (APQ) value, and to determine an optimum patrol path from the plurality of patrol paths according to the APO value and the APQ value; and a moving unit configured to move along the optimum patrol path. The method includes providing a plurality of patrol paths, each of which has an Average Patrol Omission (APO) value and an Average Patrol Quality (APQ) value; and evaluating the plurality of patrol paths according to the respective APO values and the respective APQ values so as to select an optimum patrol path therefrom. | 06-03-2010 |
20100138097 | Surface Inspecting Device - A modular surface inspecting device is provided. A modular surface inspecting device comprises a computing layer having a processing unit in which a modular service-oriented software is installed; a detecting layer having a plurality of sensors obtaining a plurality of surrounding information; and a dynamic layer carrying the computing layer and the detecting layer and controlled by a controlling command generated by the computing layer according to the plurality of surrounding information. | 06-03-2010 |